4//SEC Filing
Loiacono Michael 4
Accession 0001144204-18-054992
CIK 0001094038other
Filed
Oct 22, 8:00 PM ET
Accepted
Oct 23, 5:10 PM ET
Size
5.9 KB
Accession
0001144204-18-054992
Insider Transaction Report
Form 4
Loiacono Michael
Chief Financial Officer
Transactions
- Award
Employee Stock Option (Right to Buy)
2018-10-19+300,000→ 300,000 totalExercise: $9.18Exp: 2028-10-19→ Common Stock (300,000 underlying)
Footnotes (1)
- [F1]Represents options granted under the Company's 2014 Omnibus Stock Ownership Plan, as amended. These shares vest in monthly installments over a four year period upon the continued employment of the Reporting Person by the Company through the vesting dates. The option exercise price is the closing price on the date of the grant, October 19, 2018.
Documents
Issuer
Marker Therapeutics, Inc.
CIK 0001094038
Entity typeother
Related Parties
1- filerCIK 0001679119
Filing Metadata
- Form type
- 4
- Filed
- Oct 22, 8:00 PM ET
- Accepted
- Oct 23, 5:10 PM ET
- Size
- 5.9 KB